Friday, July 10, 2026

Patent directory · USPTO A61K / A61P

Patents matching “ARCTURUS THERAPEUTICS, INC.”

54 pharma patents match "ARCTURUS THERAPEUTICS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 54
Index total 30,257
Page 1 / 3

Quick answer

This filtered view shows 54 pharmaceutical patents matching "ARCTURUS THERAPEUTICS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

54 results for “ARCTURUS THERAPEUTICS, INC.” · 30,257 patents in full index Clear search

  1. US 12398379

    Compositions and methods for treating ornithine transcarbamylase deficiency

    ARCTURUS THERAPEUTICS, INC. · Granted Aug 26, 2025 · Expires Aug 21, 2045

    granted
  2. US 12390524

    Compositions and methods for inducing immune responses

    ARCTURUS THERAPEUTICS, INC. · Granted Aug 19, 2025 · Expires Aug 14, 2045

    granted
  3. US 12351834

    Compositions and methods for the treatment of ornithine transcarbamylase deficiency

    ARCTURUS THERAPEUTICS, INC. · Granted Jul 8, 2025 · Expires Jul 3, 2045

    granted
  4. US 12290567

    Asialoglycoprotein Receptor mediated delivery of therapeutically active conjugates

    ARCTURUS THERAPEUTICS, INC. · Granted May 6, 2025 · Expires May 1, 2045

    granted
  5. US 12286395

    Method of synthesis of an ionizable cationic lipid

    ARCTURUS THERAPEUTICS, INC. · Granted Apr 29, 2025 · Expires Apr 24, 2045

    granted
  6. US 12220485

    Method of making lipid-encapsulated RNA nanoparticles

    ARCTURUS THERAPEUTICS, INC. · Granted Feb 11, 2025 · Expires Feb 6, 2045

    granted
  7. US 12220455

    Coronavirus vaccine compositions and methods

    ARCTURUS THERAPEUTICS, INC. · Granted Feb 11, 2025 · Expires Feb 6, 2045

    granted
  8. US 12178921

    Method of lyophilizing lipid nanoparticles

    ARCTURUS THERAPEUTICS, INC. · Granted Dec 31, 2024 · Expires Dec 26, 2044

    granted
  9. US 12083224

    Lipid particles for nucleic acid delivery

    ARCTURUS THERAPEUTICS, INC. · Granted Sep 10, 2024 · Expires Sep 5, 2044

    granted
  10. US 12077754

    Synthetic transfer RNA with extended anticodon loop

    ARCTURUS THERAPEUTICS, INC. · Granted Sep 3, 2024 · Expires Aug 29, 2044

    granted
  11. US 12070509

    Nucleic acids and methods of treatment for cystic fibrosis

    ARCTURUS THERAPEUTICS, INC. · Granted Aug 27, 2024 · Expires Aug 22, 2044

    granted
  12. US 11938227

    Lipid nanoparticles encapsulation of large RNA

    ARCTURUS THERAPEUTICS, INC. · Granted Mar 26, 2024 · Expires Mar 21, 2044

    granted
  13. US 11939600

    Compositions and methods for treating phenylketonuria

    ARCTURUS THERAPEUTICS, INC. · Granted Mar 26, 2024 · Expires Mar 21, 2044

    granted
  14. US 11939363

    Translatable molecules and synthesis thereof

    ARCTURUS THERAPEUTICS, INC. · Granted Mar 26, 2024 · Expires Mar 21, 2044

    granted
  15. US 11759515

    Compositions and methods for inducing immune responses

    ARCTURUS THERAPEUTICS, INC. · Granted Sep 19, 2023 · Expires Sep 14, 2043

    granted
  16. US 11744887

    Coronavirus vaccine compositions and methods

    ARCTURUS THERAPEUTICS, INC. · Granted Sep 5, 2023 · Expires Aug 31, 2043

    granted
  17. US 11737979

    Method of making lipid-encapsulated RNA nanoparticles

    ARCTURUS THERAPEUTICS, INC. · Granted Aug 29, 2023 · Expires Aug 24, 2043

    granted
  18. US 11685921

    Molecules and agents for treating hepatitis B virus

    ARCTURUS THERAPEUTICS, INC. · Granted Jun 27, 2023 · Expires Jun 22, 2043

    granted
  19. US 11685906

    Compositions and methods for treating ornithine transcarbamylase deficiency

    ARCTURUS THERAPEUTICS, INC. · Granted Jun 27, 2023 · Expires Jun 22, 2043

    granted
  20. US 11434485

    Synthetic transfer RNA with extended anticodon loop

    ARCTURUS THERAPEUTICS, INC. · Granted Sep 6, 2022 · Expires Sep 1, 2042

    granted
  21. US 11407800

    Translatable molecules and synthesis thereof

    ARCTURUS THERAPEUTICS, INC. · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  22. US 11015204

    Synthesis and structure of high potency RNA therapeutics

    ARCTURUS THERAPEUTICS, INC. · Granted May 25, 2021 · Expires May 20, 2041

    granted
  23. US 10980895

    Ionizable cationic lipid for RNA delivery

    ARCTURUS THERAPEUTICS, INC. · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  24. US 10961535

    Compositions and agents against hepatitis B virus and uses thereof

    ARCTURUS THERAPEUTICS, INC. · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted